SCHEMBL6925937

SCHEMBL6925937

COc1ccc2c3c(O)cccc3n(Cc3ccccc3)c2c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 6/20 0.53
PLA2G10 O15496 1/20 0.52
CNR2 P34972 1/20 0.52
SRC P12931 1/20 0.50
MTNR1A P48039 1/20 0.48
MTNR1B P49286 1/20 0.48
P2RX4 Q99571 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
PLA2G1B P04054 1/20 0.46
TP53 P04637 1/20 0.46
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.45
HTT P42858 1/20 0.45
EDNRB P24530 2/20 0.45
EDNRA P25101 2/20 0.45
NTRK1 P04629 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6920467 0.90 PLA2G2A (0.55) PLA2G2AP2RX4PLA2G1B
SCHEMBL6921173 0.81 CYP19A1 (0.65) PLA2G2ASRCP2RX4HDAC1HDAC6
SCHEMBL6921601 0.79 PLA2G2A (0.47) PLA2G2APLA2G10CNR2MTNR1AMTNR1B
SCHEMBL6919685 0.78 PLA2G2A (0.44) PLA2G2APLA2G10CNR2MTNR1AMTNR1B
SCHEMBL6923659 0.75 KMT2A (0.51) PLA2G2ASRCP2RX4TP53ALDH1A1
SCHEMBL7517440 0.75 TSHR (0.56) PLA2G2AP2RX4PLA2G1BNTRK1
SCHEMBL7723992 0.75 SRC (0.53) PLA2G2ASRCP2RX4ALDH1A1POLB
SCHEMBL27901716 0.74 KMT2A (0.55) PLA2G2APLA2G10PLA2G1BTP53ALDH1A1
SCHEMBL6924327 0.74 SRC (0.51) PLA2G2ASRCP2RX4HDAC1HDAC6
SCHEMBL4169248 0.73 HASPIN (0.61) PLA2G2APLA2G10CNR2MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed